| product Name |
(S)-Alpha,Alpha-Diphenyl-3-Pyrrolidineacetamine L-Tartaric acid salt |
| Synonyms |
(S)-Diphenyl-3-pyrrolidine acetamide L-Tartaric Acid Salt; (S)-alpha,alpha-Diphenyl-3-pyrrolidineacetamide L-tartaric acid salt; Darifenacin Intermediate 5; (S)-α,α-Diphenyl-3-pyrrolidine acetamide L-Tartaric; Darifenacin Intermediate 8; (S)-Alpha,Alphal-Diphenyl-3-Pyrrolidineacetamide tartrate; 3(S)-(+)-(1-carbamoyl-1,1-Diphenylmethyl) pyrrolidine-L(+)-Tartrate; 3(S)-(+)-(1-carbamoyl-1,1-Diphenylmethyl)pyrrolidine-L(+)-Tartrate; 3-(S)-(+)-(1-Carbamoyl-1,1-diphenylmethyl)pyrroloidine-L-(+)-tartarate; 2,2-Diphenyl-2-[(3S)-pyrrolidin-3-yl]acetamide L-(+)-tartrate; 2,2-diphenyl-2-[(3S)-pyrrolidin-3-yl]acetamide 2,3-dihydroxybutanedioate (1:1); (S)-Alpha, Alphal-Diphenyl-3-Pyrrolidineacetamide L-Tartaric acid salt; 3-(S)-(1-carbamoyl-1,1-diphenylmethyl)pyrrolidine tartrate; 2,2-Diphenyl-2-[(3S)-pyrrolidin-3-yl] Acetamide L-(+)-Tartrate; 3(S)-(+)-(1-carbamoyl-1,1-Diphenylmethyl) pyrrolidine-L-(+)-Tartrate; (3S)-(1-Carbamoyl-1,1-diphenylmethyl)pyrroloidine-L-tartarate |
| Molecular Formula |
C22H26N2O7 |
| Molecular Weight |
430.45104 |
| InChI |
InChI=1/C18H20N2O.C4H6O6/c19-17(21)18(16-11-12-20-13-16,14-7-3-1-4-8-14)15-9-5-2-6-10-15;5-1(3(7)8)2(6)4(9)10/h1-10,16,20H,11-13H2,(H2,19,21);1-2,5-6H,(H,7,8)(H,9,10)/t16-;1-,2-/m11/s1 |
| CAS Registry Number |
134002-26-9 |
| Molecular Structure |
|
| Hazard Symbols |
|
| Risk Codes |
|
| Safety Description |
|
|
